The antileukemic activity of Δ12-PGJ3

Slides:

Advertisements

Similar presentations

RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.

Advertisements

Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.

CD4 T cells: fates, functions, and faults by Jinfang Zhu, and William E. Paul Blood Volume 112(5): September 1, 2008 ©2008 by American Society.

Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7): February 18, 2016 ©2016 by.

Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation.

Oxidative stress and hypoxia in normal and leukemic stem cells Ugo Testa, Catherine Labbaye, Germana Castelli, Elvira Pelosi Experimental Hematology Volume.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Phenotypic and Functional Changes Induced at the Clonal Level in Hematopoietic Stem Cells After 5-Fluorouracil Treatment by Troy D. Randall, and Irving.

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Eicosapentaenoic Acid Eicosapentaenoic acid Eicosapentaenoic acid (EPA) is an omega-3 fatty acid.

Gene therapy: efficient targeting of hematopoietic stem cells

MBL: mostly benign lymphocytes, but…

Hydroxyurea makes inflammation “just right”?

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.

Collaboration is required for successful immunotherapy

TCR-MHC-peptide(s): in vivo veritas

“Vitamin hypothesis”: explanation for allergy increase?

Neonatal GATA1 mutant clones under the radar

Fledgling prognostic markers in CLL

Finding a diamond in the (mouse is) rough

by Muhammed A. Mir, Mrinal M. Patnaik, and Joerg Herrmann

Yin and yang of glucocorticoid receptors in apoptosis

Gupta V, Tallman MS, Weisdorf DJ

When monocyte life hangs by a thread

It's all in the timing by Linda J. Bendall Blood

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Angiopoietin-2 in CLL by Jan A. Burger Blood Volume 116(4):

by Zhenping Zhu Blood Volume 108(6): September 15, 2006

Glis: novel modulators of TCR signaling?

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by.

Rituximab-induced tumor cell agglutination

BRAF inhibitor: targeted therapy in hairy cell leukemia

A cell by any other name by Narla Mohandas Blood

Darwinian evolution and tiding clones in multiple myeloma

An Unusual Cause of Abdominal Pain in Sickle Cell Disease

Functional neutrophils from human ES cells

Fluorescent neutrophils throw the spotlight on inflammation

In situ identification of allospecific B cells using pentamers

Deep mining of the RBC proteome

Acute promyelocytic leukemia, microgranular variant

How we choose factor VIII to treat hemophilia

by Jayesh Mehta Blood Volume 112(2): July 15, 2008

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Human CD27+IgM+IgD+ B cells: T-cell or TLR-dependent?

Stage C or not stage C…? by Claire Dearden Blood

by Jesmond Dalli, and Charles N. Serhan

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Lymphoma spread? Target CD47-SIRPα!

A new red cell shape helps the clot

Chemokines and chemokine receptors: here, there, and everywhere

Immunotherapy for acute lymphoblastic leukemia: from famine to feast

724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.

Sarah A. Holstein, Paul G. Richardson, Jacob P. Laubach, Philip L

Disparity in Survival Outcome after Hematopoietic Stem Cell Transplantation for Hematologic Malignancies According to Area of Primary Residence Keshav.

Volume 143, Issue 6, (December 2010)

BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1–positive B-cell acute lymphoblastic leukemia by Karen A. Dun, Rob Vanhaeften, Tracey J.

by Michael R. DeBaun, and Ellen Wright Clayton

by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther

Mammen Chandy Biology of Blood and Marrow Transplantation

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Bigger, Stronger, Faster: Chimeric Antigen Receptor T Cells Are Olympic Killers by Paul J Neeson, Alexander James Davenport, Joseph A Trapani, Michael.

TP53 Mutations in AML Predict Adverse Outcome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant by Bartlomiej M Getta, Arnab Ghosh,

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Pure red cell aplasia by Robert T. Means Blood

by Lucy A. Godley, and Akiko Shimamura

by Lapo Alinari, and Kristie A. Blum

Health-Related Quality of Life (HRQoL) of Blinatumomab Versus Standard of Care (SOC) Chemotherapy in Patients with Relaspsed or Refractory Philadelphia.

by Wolfgang Warsch, Christoph Walz, and Veronika Sexl

Cold agglutinin disease

Leukemia Stem Cells Are Characterized By CLEC12A Expression and Chemotherapy Refractoriness That Can be Overcome By Targeting with Chimeric Antigen Receptor.

Presentation transcript:

The antileukemic activity of Δ12-PGJ3 by Paul A. Ney Blood Volume 118(26):6728-6729 December 22, 2011 ©2011 by American Society of Hematology

Antileukemic activity of eicosapentaenoic acid (EPA)–derived cyclopentenone prostaglandins. Antileukemic activity of eicosapentaenoic acid (EPA)–derived cyclopentenone prostaglandins. Left panel shows a liquid chromatography-UV trace of EPA-derived metabolites endogenously produced by macrophages. Right panel demonstrates the selective antileukemic effect of Δ12-PGJ3 on BCR-ABL–transformed leukemic stem cells. Paul A. Ney Blood 2011;118:6728-6729 ©2011 by American Society of Hematology